Kepos Capital LP Abb Vie Inc. Transaction History

Kepos Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $2.4 Million - $2.88 Million	-38,052 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $2.88 Million - $3.69 Million	-43,880 Reduced 53.56%	38,052 $2.77 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $6.32 Million - $7.44 Million	81,932 New	81,932 $6.6 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $5.69 Million - $7.02 Million	-73,108 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $184,754 - $205,389	2,078 Added 2.93%	73,108 $6.92 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $1.5 Million - $1.77 Million	16,688 Added 30.71%	71,030 $6.58 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $461,614 - $618,144	5,017 Added 10.17%	54,342 $5.14 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $4.42 Million - $4.84 Million	49,325	49,325 $4.77 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.